Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention.
about
Structural Properties of Gene Promoters Highlight More than Two Phenotypes of DiabetesInterventions for latent autoimmune diabetes (LADA) in adultsInterventions for latent autoimmune diabetes (LADA) in adultsGenes, diet and type 2 diabetes mellitus: a reviewGuidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodiesAn Audit of Insulin Usage and Insulin Injection Practices in a Large Indian Cohort.Adiponectin levels in people with Latent Autoimmune Diabetes-a case control study.Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.Current oral agents for type 2 diabetes. Many options, but which to choose when?Diabetes mellitus: The epidemic of the century.Insulin resistance in type 1 diabetes.Genetically defined pancreatic beta cell failure.Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetesLatent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-RequirementA practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes.Prevalence and clinical characteristics of recently diagnosed type 2 diabetes patients with positive anti-glutamic Acid decarboxylase antibody.Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)Latent autoimmune diabetes of adulthood. Unique features that distinguish it from types 1 and 2.Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?LADA: time for a new definition.Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study.Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in SwedenPotential role of stem cell therapy in type 1 diabetes mellitus.Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents.Autologous stem cell transplantation for early type 1 diabetes mellitus.Insulin therapy in people with type 2 diabetes: opportunities and challenges?Beta-cell protection and therapy for latent autoimmune diabetes in adults.Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes.The broad clinical phenotype of Type 1 diabetes at presentation.Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy.Combination immunotherapies for type 1 diabetes mellitus.Beyond Genetics: What Causes Type 1 Diabetes.Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).Differential Expression of Metabolism-related Genes in Liver of Diabetic Obese RatsIs there a role for gut microbiota in type 1 diabetes pathogenesis?Glutamic acid decarboxylase and islet antigen 2 antibody profiles in people with adult-onset diabetes mellitus: a comparison between mixed ethnic populations in Singapore and Germany.Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes.Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulinCombined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults.
P2860
Q22065149-018D3944-41E4-4C48-8F28-3754995087E3Q24234365-35846DAC-A889-47EC-9730-0996F76E7552Q24244270-33539F84-47CE-4353-B29C-EAE991536DF8Q24672249-539200C5-C207-4535-9CC3-BF27D6F2E334Q30426632-E1C5D427-2710-465C-81BA-29D6C8A63933Q33585748-723C76FA-9FDE-4A72-8968-914C2291B684Q33697513-D14A1294-F7C8-4D72-94E1-D906A3E7599DQ33751927-47C23393-AD68-4610-9FE4-99829755DEDDQ34066900-44073406-B367-4131-8761-13BEFD9ED80EQ34663240-4A02CD98-6AFC-4551-B7EE-EF25342CA631Q34671155-9CD084DE-B271-47EE-BD16-55D75E59E71EQ34733637-C96D5902-ABFB-44E0-8341-88CE1D71AB9FQ34837085-5C11DCBC-F859-47E3-B31E-EDDCE83A4E4DQ35010284-A2F8AFE5-5663-4597-AB58-AD81F1EB2A73Q35740110-720FAF03-A010-43F6-9541-D423205EB7B6Q35828121-99EE6744-DEB5-40FE-8B58-4B220232CE3EQ35911077-1DF405C9-2454-4363-8054-532545073833Q35919326-D331C698-AA67-43BB-9111-BE22D3B3C4B5Q36077018-88306385-85B1-4909-9E18-654C0A3BF8EFQ36152957-98E13BF7-41B5-4A73-93B1-73A82635BF1FQ36560625-1839FD3D-4DDB-49A4-9027-4C99D8997BE9Q36711786-82541B33-BACF-42E1-AF07-75B0409A2396Q37067132-26692653-EB05-4342-9D51-C25C3245B0DBQ37148319-EEB4DEB5-CD36-4696-B553-1D6A04E6E949Q37161925-633300AD-F436-47FD-BFEC-074C136BF942Q37311060-08FFDFAA-9C40-499C-9224-998F12FD5104Q37461707-5F899500-5845-4677-B004-80584751C9ACQ37624274-FCBE74CB-2809-4B97-ABF4-37CB0F02685BQ38032163-D9D7B690-2EB3-4106-B868-9BDE3E848A9FQ38052934-E95C6959-6AFA-47E4-BE61-BED3849F00F6Q38071010-78822D8D-4897-40B0-8F94-8A909F56056BQ38358009-05C05EC4-6718-4DBD-8FAE-959133A4DB18Q39017669-1CFCA71D-6BE0-4019-ACF0-4E096788BB14Q40524112-C9FE17EF-BB12-44B8-9A24-1BF7F81E2BA4Q40537811-6EA21CB4-75BA-4651-9E65-006C521653D1Q40631825-2BA2ED8B-AEC7-4566-994E-2737DD417B7FQ41551735-31963C1C-3F60-4476-BE33-861C14F2E9B8Q41751849-A16776EC-6677-4900-BC24-A17353F9DA92Q41909159-98BAB9A5-9AF5-4865-9F40-677E7EF690C1Q42233629-76253BF0-4B93-4ADB-8985-7A88F4FFF00A
P2860
Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Autoimmune diabetes not requir ...... ion, and potential prevention.
@ast
Autoimmune diabetes not requir ...... ion, and potential prevention.
@en
Autoimmune diabetes not requir ...... ion, and potential prevention.
@nl
type
label
Autoimmune diabetes not requir ...... ion, and potential prevention.
@ast
Autoimmune diabetes not requir ...... ion, and potential prevention.
@en
Autoimmune diabetes not requir ...... ion, and potential prevention.
@nl
prefLabel
Autoimmune diabetes not requir ...... ion, and potential prevention.
@ast
Autoimmune diabetes not requir ...... ion, and potential prevention.
@en
Autoimmune diabetes not requir ...... ion, and potential prevention.
@nl
P1433
P1476
Autoimmune diabetes not requir ...... ion, and potential prevention.
@en
P2093
Di Mario U
Pozzilli P
P304
P356
10.2337/DIACARE.24.8.1460
P407
P577
2001-08-01T00:00:00Z